Destabilization of survival factor MEF2D mRNA by neurotoxin in models of Parkinson's disease
- PMID: 24848448
- DOI: 10.1111/jnc.12765
Destabilization of survival factor MEF2D mRNA by neurotoxin in models of Parkinson's disease
Abstract
Progressive loss of dopaminergic (DA) neurons in the substantial nigra pars compacta (SNc) is an important pathological feature in Parkinson's disease (PD). Loss of transcription factor myocyte enhancer factor 2D (MEF2D), a key neuronal survival factor, has been shown to underlie the loss of DA neurons in SNc and the pathogenic process of PD. It is known that PD-associated neurotoxins reduce the level of MEF2D protein to trigger neuronal death. Although neurotoxins clearly destabilize MEF2D by post-translational mechanisms, it is not known whether regulation of MEF2D mRNA contributes to neurotoxin-induced decrease in MEF2D protein. In this work, we showed that MPP(+), the toxic metabolite of MPTP, caused a significant decrease in the half-life and total level of MEF2D mRNA in a DA neuronal cell line, SN4741 cells. Quantitative PCR analysis of the SNc DA neurons captured by immune-laser capture microdissection showed that exposure to MPTP led to a marked reduction in the level of MEF2D mRNA in SNc DA neurons compared to controls. Down-regulation of MEF2D mRNA alone reduced the viability of SN4741 cells and sensitized the cells to MPP(+)-induced toxicity. These results suggest that destabilization and reduction in MEF2D mRNA is in part responsible for neurotoxin-induced decrease in MEF2D protein and neuronal viability. Myocyte enhancer factor 2D (MEF2D) plays an important role in neuronal survival. How MEF2D mRNA is deregulated under toxic stress is unclear. We found that PD-associated neurotoxins destabilize MEF2D mRNA and reduce its level in vitro and in vivo. Reduction in MEF2D mRNA is sufficient to sensitize model cells to neurotoxin-induced toxicity, suggesting that destabilization of MEF2D mRNA is part of the mechanism by which neurotoxins trigger deregulation of neuronal survival.
Keywords: MPTP/MPP+; Parkinson's disease; mRNA; transcription factor myocyte enhancer factor 2D.
© 2014 International Society for Neurochemistry.
Similar articles
-
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B.Neuropharmacology. 2017 Nov;126:12-24. doi: 10.1016/j.neuropharm.2017.08.014. Epub 2017 Aug 12. Neuropharmacology. 2017. PMID: 28807675
-
Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.J Biol Chem. 2012 Oct 5;287(41):34246-55. doi: 10.1074/jbc.M112.367540. Epub 2012 Aug 13. J Biol Chem. 2012. PMID: 22891246 Free PMC article.
-
Salidroside protects dopaminergic neurons by regulating the mitochondrial MEF2D-ND6 pathway in the MPTP/MPP+ -induced model of Parkinson's disease.J Neurochem. 2020 Apr;153(2):276-289. doi: 10.1111/jnc.14868. Epub 2019 Oct 27. J Neurochem. 2020. PMID: 31520529
-
Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins.Neurotoxicology. 2011 Oct;32(5):563-6. doi: 10.1016/j.neuro.2011.05.019. Epub 2011 Jun 29. Neurotoxicology. 2011. PMID: 21741404 Free PMC article. Review.
-
Changes in cytokines and neurotrophins in Parkinson's disease.J Neural Transm Suppl. 2000;(60):277-90. doi: 10.1007/978-3-7091-6301-6_19. J Neural Transm Suppl. 2000. PMID: 11205147 Review.
Cited by
-
Role of Chaperone-Mediated Autophagy Dysfunctions in the Pathogenesis of Parkinson's Disease.Front Mol Neurosci. 2016 Dec 23;9:157. doi: 10.3389/fnmol.2016.00157. eCollection 2016. Front Mol Neurosci. 2016. PMID: 28066181 Free PMC article. Review.
-
Evaluating the mouse neural precursor line, SN4741, as a suitable proxy for midbrain dopaminergic neurons.BMC Genomics. 2023 Jun 7;24(1):306. doi: 10.1186/s12864-023-09398-y. BMC Genomics. 2023. PMID: 37286935 Free PMC article.
-
Potent Protection Against MPP+-Induced Neurotoxicity via Activating Transcription Factor MEF2D by a Novel Derivative of Naturally Occurring Danshensu/Tetramethylpyrazine.Neuromolecular Med. 2016 Dec;18(4):561-572. doi: 10.1007/s12017-016-8399-5. Epub 2016 Jun 8. Neuromolecular Med. 2016. PMID: 27277280
-
Transcription Factors: Potential Cell Death Markers in Parkinson's Disease.Neurosci Bull. 2017 Oct;33(5):552-560. doi: 10.1007/s12264-017-0168-4. Epub 2017 Aug 8. Neurosci Bull. 2017. PMID: 28791585 Free PMC article. Review.
-
Transcription factor myocyte enhancer factor 2D regulates interleukin-10 production in microglia to protect neuronal cells from inflammation-induced death.J Neuroinflammation. 2015 Feb 20;12:33. doi: 10.1186/s12974-015-0258-z. J Neuroinflammation. 2015. PMID: 25890150 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous